1. Home
  2. QNRX vs CISS Comparison

QNRX vs CISS Comparison

Compare QNRX & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • CISS
  • Stock Information
  • Founded
  • QNRX 2018
  • CISS 2022
  • Country
  • QNRX United States
  • CISS Greece
  • Employees
  • QNRX N/A
  • CISS N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • CISS Marine Transportation
  • Sector
  • QNRX Health Care
  • CISS Consumer Discretionary
  • Exchange
  • QNRX Nasdaq
  • CISS Nasdaq
  • Market Cap
  • QNRX 3.3M
  • CISS 2.8M
  • IPO Year
  • QNRX N/A
  • CISS N/A
  • Fundamental
  • Price
  • QNRX $9.60
  • CISS $3.30
  • Analyst Decision
  • QNRX
  • CISS
  • Analyst Count
  • QNRX 0
  • CISS 0
  • Target Price
  • QNRX N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • QNRX 12.9K
  • CISS 121.3K
  • Earning Date
  • QNRX 08-07-2025
  • CISS 08-21-2025
  • Dividend Yield
  • QNRX N/A
  • CISS N/A
  • EPS Growth
  • QNRX N/A
  • CISS N/A
  • EPS
  • QNRX N/A
  • CISS N/A
  • Revenue
  • QNRX N/A
  • CISS $38,174,754.00
  • Revenue This Year
  • QNRX N/A
  • CISS N/A
  • Revenue Next Year
  • QNRX N/A
  • CISS N/A
  • P/E Ratio
  • QNRX N/A
  • CISS N/A
  • Revenue Growth
  • QNRX N/A
  • CISS N/A
  • 52 Week Low
  • QNRX $5.01
  • CISS $2.85
  • 52 Week High
  • QNRX $54.95
  • CISS $23.25
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 64.78
  • CISS 41.14
  • Support Level
  • QNRX $8.04
  • CISS $3.20
  • Resistance Level
  • QNRX $8.58
  • CISS $4.00
  • Average True Range (ATR)
  • QNRX 0.46
  • CISS 0.37
  • MACD
  • QNRX 0.04
  • CISS -0.03
  • Stochastic Oscillator
  • QNRX 98.57
  • CISS 8.33

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: